Expanding from Switzerland into the United Kingdom
UK Company Formation for Founders and Investors Based in Switzerland
Supporting Swiss businesses establishing, operating and expanding through a professionally structured UK corporate presence.
Executive summary
Why Swiss businesses look to the United Kingdom
Switzerland's UK-facing activity clusters around three long-standing strengths: private wealth and family-office management, pharmaceutical and life-sciences groups headquartered around Basel and Zurich, and precision manufacturing and instrumentation businesses trading internationally. Swiss family offices and private investors regularly use a UK limited company as a discrete operating or holding arm alongside a Swiss AG or GmbH, valuing the UK's well-understood corporate register and its separation from Swiss banking-secrecy considerations that no longer apply in the same way they once did. Pharmaceutical and precision-engineering founders use a UK entity for commercial and distribution activity into the UK market, distinct from regulated manufacturing or clinical functions that remain in Switzerland. Across all three groups, the emphasis is less on cost than on structural clarity and a UK banking relationship that reflects genuine substance. We advise on structure, address, compliance and banking readiness — never on Swiss or UK tax positioning.
Businesses based in Switzerland expand internationally for reasons that are commercial before they are administrative: a larger addressable market, counterparties who expect a locally contracting entity, access to capital that is unavailable domestically, and the need to hold intellectual property and revenue contracts in a jurisdiction their clients and investors already understand. The United Kingdom remains one of the most straightforward jurisdictions in which to establish that presence, provided the structure is designed deliberately rather than assembled through a low-cost registration service.
This guide is written for founders, directors and finance leads of Swiss businesses who have decided, or are close to deciding, that a UK corporate presence is required — and who want to understand the structural, compliance and banking implications before they commit. It sets out the market context we see across Switzerland, the sectors we most frequently support, the considerations specific to Swiss ownership, and the advisory services usually engaged at each stage. It is guidance, not a substitute for regulated legal, tax or financial advice on your specific circumstances.
Market overview
The Switzerland business landscape
The profile of a business shapes how a UK entity should be structured, how banks will assess it, and which obligations arise first. These are the segments of the Switzerland economy from which we most frequently receive instructions.
- Private wealth and family office
- Pharmaceuticals and life sciences
- Precision engineering and instrumentation
- Investment and holding structures
- International trade
Typical client profiles
- Private investors and family offices operating UK-facing holdings.
- Pharmaceutical and life-sciences groups establishing UK commercial or distribution activity.
- Precision-engineering and instrumentation exporters trading internationally.
- Executives establishing a personal UK operating company.
Industries we commonly support
Sectors instructing us from Switzerland
- Private wealth and family office
- Pharmaceuticals and life sciences
- Precision engineering and instrumentation
- Investment and holding structures
- International trade
Why the United Kingdom
Why businesses from Switzerland choose the UK
International credibility, English law contracting, enterprise procurement acceptance, holding-company architecture, investor familiarity, access to international banking and a base for further global expansion.
- Recognised English-law vehicle for private-wealth and family-office holding or operating structures.
- A commercial and distribution entity for pharmaceutical and precision-engineering groups, distinct from Swiss regulated or manufacturing functions.
- A credible operating counterpart to a Swiss AG or GmbH, well understood by Swiss private banks.
- Access to UK banking and payment infrastructure with a well-documented, transparent register.
Advisory services commonly requested
Engagements typically instructed from Switzerland
- UK Company Establishment Advisory
Entity selection, share structure, directors and the incorporation file prepared as an advisory exercise.
- Business Banking Readiness Advisory
Preparation of the corporate record, ownership narrative and documentation a UK bank or payment provider expects.
- VAT, EORI and HMRC Registration Support
Registration sequencing and coordination with HMRC-facing obligations where the business trades cross-border.
- Companies House Compliance Advisory
Confirmation statements, PSC accuracy, statutory registers and a mapped filing calendar.
- Holding Company and Group Structuring Advisory
Where the UK entity should sit within an existing overseas group, and what that means for control and value.
- Corporate Governance and Ongoing Support
Board discipline, statutory maintenance and continuing advisory support as the UK entity operates.
Switzerland-specific considerations
Considerations for Swiss businesses
Formation and entity selection
Structure is often more layered for Swiss principals — shareholder identity, corporate shareholders, share classes — and is agreed before filing. Family offices in particular benefit from mapping the intended UK role (operating, holding or both) before incorporation.
Directors and shareholders
Swiss directors and corporate shareholders are welcome. Identity verification and, where relevant, corporate resolutions from a Swiss AG or GmbH are prepared in advance.
Registered and service addresses
Registered Office, Director Service Address and Virtual Business Address form a coherent operating footprint for Swiss principals without UK premises.
Companies House compliance
UK confirmation statements, PSC updates and Companies House filings are handled on the company's calendar, entirely separate from Swiss commercial-register obligations.
Business banking expectations
Swiss founders and family offices typically benefit from a well-prepared source-of-funds narrative and structural clarity, particularly given how closely UK banks now scrutinise cross-border wealth structures. UK banks respond to that clarity; approval remains with the bank.
Payment provider readiness
Payment provider readiness follows the same principle: consistent, verifiable documentation, especially important for pharmaceutical and precision-engineering groups whose activity description must match their actual UK trade precisely.
Cross-border considerations
Corporate tax residence and permanent establishment questions are typically reviewed with a Swiss adviser. We may coordinate an introduction to an appropriate independent professional, particularly where a family office is structuring UK and Swiss holdings together.
VAT and EORI
UK VAT and EORI registration are coordinated where required, including for precision-engineering exporters moving goods between Switzerland and the UK.
Recommended pathway
A considered UK Business Experts service pathway
Concierge Complete is the common choice for Swiss investors, family offices and pharmaceutical groups given structural complexity; Executive suits simpler operating companies.
Frequently asked questions
Swiss founder questions
Can a Swiss AG hold shares in a UK Ltd?+
Yes. Corporate shareholders are recorded on the PSC register; we prepare the required documentation.
Is a UK Ltd suitable for holding investments?+
It can be, subject to structural review. Broader tax planning should involve an appropriate independent professional.
Can a Swiss family office use a UK Ltd alongside Swiss holding structures?+
Yes, subject to careful structural planning. We coordinate the UK entity; overall group tax and legal structuring sits with independent Swiss and UK professionals.
Does a Swiss pharmaceutical group need UK regulatory approval alongside a UK Ltd?+
Regulated pharmaceutical activity requires separate UK licensing (such as MHRA approval where relevant), which sits outside our advisory.
Related Executive Insights
Further reading
Business Operations
Building a UK Holding Company for International ExpansionHow international groups use a UK holding company to centralise ownership, simplify governance and present a coherent structure to banks and investors — and when the holding layer is not the right answer.
Banking and Payments
Building a Bank-Ready UK Business: A Strategic Guide for International FoundersWhy UK banks and electronic money institutions decline internationally-owned companies more often than they approve them, and how founders can build a coherent, evidence-backed application before they ever submit one.
UK Market Entry
How AI Companies Establish and Scale in the United KingdomA practical assessment of why artificial intelligence and deep-technology businesses incorporate in the United Kingdom, and how they structure entities, intellectual property, banking, and governance to withstand investor and enterprise scrutiny.
Business Operations
The Investor-Ready UK Corporate Structure for SaaS BusinessesHow UK SaaS founders prepare share structure, statutory registers, vesting and merchant onboarding records so that an investment round or acquisition proceeds without avoidable delay or valuation friction.
Next step
Planning to establish your UK presence?
Arrange a confidential discussion with our advisory team. We will review your position in Switzerland, the structure you are considering, and the sequence of work required before the UK entity begins trading.
Last reviewed: 2026-07-23